Agenda November 2019

*The Peptide Certification faculty have asked that presentations for this track not be made available until Thursday, November 7th. Participants will receive their password at the course.

Wednesday November 6th

Practice Management Workshop

Discover the best practices for your Age Management Medicine practice, whether new, part- or full-time. This open-forum workshop lays it all out for you, helping you develop marketable programs, understand the process of transitioning into Age Management and how to build market share and protect your practice. In addition learn how to incorporate Exosomes a new paradigm in Medicine and Fitness Programs and an Exercise Physiologist into your practice to both expand and provide optimum patient results. This is an opportunity to listen to and speak with professionals in the industry.

Non-CME symposium sponsored by AMMG

Time
Presentation
6:00 – 6:45 pm Building a Bulletproof Marketing Blueprint to Grow Your Age Management Medicine Practice
Audrey Neff
Marketing Director, Crystal Clear Digital Marketing
Most physicians that operate any type of elective medical practice offering cash-based procedures have one thing in common: They went to medical school, not business school. This represents a major challenge in the elective medical space because the second their doors open, they need to start running their practice as a retail business. To do this successfully, the first step any practice owner or physician needs to take is to analyze their business goals and create a rock-solid marketing blueprint. A successful marketing blueprint should map out your strategy for marketing to the pre-patient, new patient, as well as the existing patient. In this lecture, attendees will understand modern patient behavior as it relates to anti-aging and wellness and take a deeper dive into all the components behind building a bulletproof marketing blueprint.
6:45 – 7:30 pm Exosomes: Current Clinical Applications and Future Directions
William Kapp III, M.D., MS, FAAOS
Founder, Chairman/CEO, Longevity Bioimaging/Landmark Hospitals, Naples, FL
Exosomes and their applications represent the newest frontier in clinical medicine. This session will explore the historical discovery of exosomes, how and where they are generated. Early clinical results for treatment of osteoarthritis, pain, hair restoration, COPD, CHF, pulmonary artery hypertension and age related decline will be presented. Future directions for exosome clinical applications will discuss the status of current IRB studies and opportunities for interested clinicians to collaborate to advance the science of exosome treatments.
7:30 – 8:00 pm You Took a Hormone Course, Now What? The Nuts and Bolts of Building a Hormonal Practice from Operations, Marketing, and Legal Aspects
Angela DeRosa, D.O., MBA, CPE
Founder & President, Hormonal Health Institute, Scottsdale, AZ
So you took a hormone course and now you are left scratching you head. “Now what?” you ask. This is a very familiar tale, with clinicians who have taken weekend courses on BRHT and are left with no idea how to take the steps to incorporate what they have learned into a successful clinical strategy. More importantly, they may not know the proper steps to protect themselves legally as well as from board actions. To make matters worse, they are also frustrated as they have no idea how to market their new learnings or how to separate from “the pack” of the ever growing competitive marketplace.  During this presentation, attendees will learn necessary steps and actions to operationalize hormones into their practice as well as legal considerations and protection. In addition, they will learn best strategies in marketing and how to lead the way into a successful hormonal practice.
8:00 – 8:45 pm Incorporating Fitness and the Use of an Exercise Physiologist in a Clinical Practice to Obtain Superior Patient Outcomes
Steven M. Villagomez, M.Ed.
Exercise Physiologist Strength & Conditioning
Associate Professor, School of Health Studies, Long Island University
Co-Founder & CEO – Kaizen Health Systems
Francisco Carreño-Galvez, Ph.D.
Exercise Physiologist Strength & Conditioning, Certified Nutrition Coach, Cellular Nutrition Expert
Adjunct Professor. School of Health Studies, Long Island University
Co-Founder & Executive Vice-President, Kaizen Health Systems
This workshop will help clinicians understand how to incorporate the use of fitness protocols into their practice, and understand the skills that an exercise physiologist can bring to the table, such as Functional Assessment of Patients using Cardiorespiratory fitness, Pulmonary function, Resting Metabolic Rate, Strength testing, Heart Rate Variability, Body Composition Interpretation and Endothelial function. Also, how an exercise physiologist can assist in designing individualized fitness programs for patients to reach optimum outcomes.
8:45 – 9:00 pm Open Forum Q &A for All Speakers

Wednesday, November 6th

Advanced Diagnostic and Treatment of Neuro Recovery Protocols for Traumatic Brain Injury - Day 1

This expanded two-day course taking TBI to the next level, will provide attendees with overwhelming information culled from peer-reviewed articles and Dr. Gordon’s practice and research on Traumatic Brain Injury as the causative factor for personality changes, cognitive impairment and mood disorders leading up to suicide. The attendees will be walked through the literature discussing the effects of primary trauma and the secondary effects of inflammation and oxidative stress on functionality. In addition, evidence-based Clinical Protocols will be presented and discussed and attendees will be taken through a series of core and advanced cases involving TBI.

Time
Presentation
8:00 – 9:00 am Introduction to Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
9:00 – 10:00 am Neurology of Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
10:00 – 10:15 am Break 
10:15 – 11:15 am Neuropathology of Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
11:15 am – 12:00 pm The Neuropermissive Environment
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
12:00 – 1:30 pm Lunch Break
1:30 – 3:00 pm Neuroendocrinology of Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
3:00 – 3:15 pm Break
3:15 – 4:15 pm Peptides and Brain Health
Edwin Lee, M.D.
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Co-Founder, Clinical Peptide Society
4:15 – 5:30 pm Neuropsychobiology of Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee

Thursday, November 7th

Certification: Essential Knowledge in the Clinical Use of Peptides for Age Management Medicine

The use of Peptides and Peptide Therapies has experienced exponential growth over the past few years. Their uses range from impacting hormonal change, to antibiotic properties, to treatments for conditions of aging such as cancer, cardiovascular health, memory & brain health and sexual function. AMMG in conjunction with the Clinical Peptide Society have an educational mandate is to fill knowledge gaps for physicians and healthcare professionals. This course is a focused track on essential knowledge in the clinical use of peptides for Age Management including a final examination for Certification.

In conjunction with the Clinical Peptide Society

  1. 8.25 hrs of Home Study Online — You can begin the online study immediately and complete at your own pace. Completion of the online course is a prerequisite to certification. The Clinical Use of Peptides and Peptide Therapies – Full Course course is included in the Certification registration cost. After registering you will receive an email with a coupon code to redeem your free course.
  2. 7 hrs Live Training at AMMG Conference — This full day live course will be held November 7 at the AMMG Conference in Tucson, Arizona.
  3. Comprehensive Final Exam — The final exam will be given Immediately following the last lecture at the live course which will be held November 7 at the AMMG Conference in Tucson, Arizona.
Time
Presentation
7:00 – 7:45 am Compounds Used in BHRT with PDE-5 Inhibitors
Presented by Dr. Eugene Shippen & David J. Metayer
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 – 8:30 am Introduction of Peptides (which hormones are peptides, with which receptors do they interact, history of the discovery of peptides, and understand that peptides have a pleiotropic effect)
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Co-Founder, Clinical Peptide Society
The world of peptides therapy is a growing field in medicine ranging from improving skin care, to growth hormone, to one’s immune system, to name a few. On Pub Med there are over 2.5 million articles on peptides. It is estimated that humans have over 250,000 peptides and we only understand a fraction of them. Peptides are chains of amino acids linked together by a polypeptide bond. The formation of a polypeptide bond by a dehydration synthesis will be reviewed. The difference between a peptide and a protein will be delineated. In addition the mechanism of action on how peptides work will be reviewed. The history of peptides will be covered and also knowing which hormones are peptides will be reviewed. Peptides have pleotropic effects and during the conference this subject will be addressed.
8:30 – 9:30 am Peptides to Increase Growth Hormone (CJC 1295, Ipamorelin, Tesamorelin, GHRP-6 and others)
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Co-Founder, Clinical Peptide Society
Growth hormone is an essential hormone in lowering body fat, improving on lipids, keeping muscles healthy and improving on bone density. Adult growth hormone deficiency symptoms will be reviewed and the association of higher mortality with growth hormone deficiency. Unfortunately the treatment with recombinant human growth hormone is not covered under most insurance plans, and it is cost prohibitive for most people. There is an alternative to the expensive recombinant human growth hormone most commonly used for boosting IGF-1 and it has the advantage of inducing all five of the hGH isoforms rather just the one that is found in the synthetic form. CJC-1295, Ipamorelin, GHRP-6, Teslomorelin and others are peptides that have been shown to help improve IGF-1 levels.
9:30 – 10:15 am Review Thymosin Alpha 1 and Thymosin Beta 4. Discuss Dosing, Data of the Safety of Each of the Peptides
Luis Martinez, M.D., MPH
President, XanoGene Clinic, Rio Pedras, Puerto Rico
President, Regenera Global
Co-Founder, Clinical Peptide Society
Co-Founder, Clinical Peptide Society
The thymosins are a group of peptides originally associated with the thymus gland. They possess pleiotropic effects on in humans. Thymosin Alpha 1 has long been studied for its immune enhancing properties, with regulatory approvals in the management of certain viral diseases and cancers. On the other hand, Thymosin Beta 4 has been shown to improve regeneration in multiple tissues. This lecture will cover the fundamentals of integrating both Thymosin Apha 1 and Thymosin Beta 4 into clinical practice. Dosing, indications and review of current literature will be presented.
10:15 – 10:30 am Break
10:30 – 11:15 am Peptide BPC-157 – Total Body Healing Peptide Including Dosing Protocols
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Co-Founder, Clinical Peptide Society
BPC-157 was discovered in the 1990’s in gastric juice. However I give credit to Dr. Pavlov in Russia in the early 1900’s since he was manufacturing gastric juice from dogs to help heal many alignments. At that time they did not have the technology to detect BPC-157. BPC-157 has been studied extensively in animals and has been shown to improve on healing the body. Studies with BPC-157 have been shown to heal a severed tendon, nerve, and also ulcers. Although there are no human clinical trials the body builders has been using BPC-157 experimentally to repair their torn muscles, tendons and ligaments. In this lecture the published studies of BPC-157 ranging from colitis, inflammatory bowel disease, systemic steroid impaired muscle healing, bone defect, periodontitis, and others will be reviewed. Although the FDA has not approved this peptide, BPC-157 has been used worldwide.
11:15 am – 12:00 pm Peptides for Autoimmune Conditions, Including Dosing
Luis Martinez, M.D., MPH
President, XanoGene Clinic, Rio Pedras, Puerto Rico
President, Regenera Global
Co-Founder, Clinical Peptide Society
Co-Founder, Clinical Peptide Society
Millions of Americans suffer from autoimmune diseases. Immune dysregulation, a universal characteristic of autoimmune diseases, can be targeted through the use of specific peptides. This lecture will present the rationale for utilizing peptide therapy in the management of autoimmune diseases. T cell modulation, cell predominant shifts, OGF axis and other mechanisms of action will be highlighted. VIP, thymosins and other peptides will be covered. Cases and protocols will be discussed.
12:00 – 1:30 pm Lunch Break
12:00 – 1:00 pm The Most Common Dysfunctions of the Standard American Gut in Chronic Illness
Presented by Kiran Krishnan
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs
1:30 – 2:15 pm Cancer Peptides with Dosages: Includes Case Studies of Cancer Cases Using Peptides
Luis Martinez, M.D., MPH
President, XanoGene Clinic, Rio Pedras, Puerto Rico
President, Regenera Global
Co-Founder, Clinical Peptide Society
Co-Founder, Clinical Peptide Society
Advances in peptide biology have shed light on multiple pathways which can be targeted for therapeutic interventions with the use of peptides. These can be incorporated as part of a comprehensive cancer management approach. The lecture will discuss peptide classes, mechanisms of action and proposed protocols for incorporating peptide therapy in the treatment of cancer patients. Peptides including Met-Enkephalin, PNC 27, P18 among others will be discussed. Oncostatic and oncolytic characteristics will be reviewed. Dosing protocols and cases will be presented.
2:15 – 3:00 pm Neuroregenerative Peptides: Includes Discussion of Dosages and Safety Protocols
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Co-Founder, Clinical Peptide Society
An estimated 6 million Americans have Alzheimer’s disease, 10 million people worldwide with Parkinson’s, 3 million Americans suffer from traumatic brain injury (TBI), and approximately 800,000 will suffer from a stroke each year. There are peptides that have been shown to have neuroregenerative properties that have clinical studies in strokes, traumatic brain injury, Parkinson’s and in Alzheimer’s disease. There are many mechanisms that are involved with neurodegenerative diseases to traumatic brain injury. Inflammation in the brain, excessive oxidative stress, mitochondrial impairment, and excitotoxicity are common theme that can lead to damage or death of the neuron or myelin. Peptides have been shown to reduce inflammation, reduce oxidative stress, increase the production of brain derived neurotrophic factor and also increase the production of neurons. The peptides of Thymosin Beta 4, BPC-157, Cerebrolysin, Dihexa and Semax will be covered.
2:30 pm Exhibits Open
3:00 – 3:45 pm Break / Visit Exhibits
3:45 – 4:15 pm Peptide PT 141, Melanotan and Epithalon
Luis Martinez, M.D., MPH
President, XanoGene Clinic, Rio Pedras, Puerto Rico
President, Regenera Global
Co-Founder, Clinical Peptide Society
Co-Founder, Clinical Peptide Society
Alpha melatonin stimulating hormone analogues, including PT 141 and Melanotan, can act on multiple melanocortin receptors. As such, they have been studied and are currently being used for multiple indications, including increasing libido, altering skin pigmentation and modulating food intake. Epitalon is a pineal peptide, originally studied in Russia. It has been shown to activate telomerase, restore melatonin secretion and reduce mortality in users. This lecture will review both pineal and pituitary physiology as they relate to these peptides. Melanocortin receptors and neuropetides will be discussed. Dosing and protocols for PT 141, Melanotan and Epitalon will be highlighted.
4:15 – 5:00 pm Question and Answer Session with Faculty
Edwin Lee, M.D., FACE & Luis Martinez, M.D., MPH
5:00 – 5:30 pm Peptides Certification Examination
Mary Corry, R.N. — Exam Proctor
Medical Education Specialist, Worldlink Medical, Salt Lake City, UT
Member, AMMG Conference Planning Committee
Member, Sigma Theta Tau International Honor Society of Nursing
5:30 – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Thursday, November 7th

Introduction to Core Issues in Age Management Medicine

Course is designed to familiarize physicians and healthcare professionals with the basics of Age Management Medicine. Covers evidence-based use of nutrition, supplements, fitness, hormones—including a specialized lecture on hGH and assessment protocols—and legal basics, with some of the newest medical science on aging that may be in use now or in the near future; including relevant case presentations and discussion.

Time
Presentation
7:00 – 7:45 am Compounds Used in BHRT with PDE-5 Inhibitors
Presented by Dr. Eugene Shippen & David J. Metayer
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 – 9:00 am Basic Hormone Replacement/Replenishment for Men
Neal Rouzier, M.D.
Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
Prescribing hormones for men is simple and straightforward. However, dealing with the problems and complications is not. This lecture will address common problems, complications, side effects, monitoring, understanding levels, erythrocytosis vs. polycythemia, prostate cancer and elevated PSA, use of 5 alpha reductase inhibitors, and aromatase inhibitors.
9:00 – 10:00 am Hormone Supplementation for Women: Essentials for Competent, Effective Prescribing
Kathryn Retzler, N.D.
Private Practice, HormoneSynergy Clinic LLC, Portland, OR
This lecture will provide an overview of proper assessment of women before hormone prescribing, available options for bioidentical estradiol, progesterone, and testosterone, dosage ranges, and appropriate follow-up. Emphasis will be placed on research along with significant clinical experience of the speaker.
10:00 – 10:15 am Break
10:15 am – 11:15 am Clinical Use of Supplements in an Age Management Medicine Practice
Rebecca Murray, APRN, FNP-BC, CDE
Endocrine Nurse Practitioner, Institute for Hormonal Balance, Orlando, FL
Medical Director, Ward-Murray HealthCare Consulting, Groton, CT
Scientific Advisory Board, Designs for Health
As practitioners in functional medicine and “age management,” our patients expect that we have and utilize the best options to guide them to optimize their health and protect them from the common problems associated with aging such as heart failure, stroke, osteoporosis, and cognitive impairment. Contrary to the standard RDA for nutrients, various factors that contribute to a person’s actual needs include: decreased ability to absorb nutrients, medications that many deplete the body of certain nutrients, and environmental factors that contribute to a greater need. This presentation will provide an overview of the mechanism of action of nutraceuticals and supplements in the protection from the untoward effects of inflammation, oxidative damage, endothelial dysfunction and how they can be applied in your practice for the prevention and treatment of common medical conditions seen in the aging population.
11:15 am – 12:00 pm Improving Growth Hormone With and Without Growth Hormone
Edwin N. Lee, M.D., FACE
Assistant Professor of Internal Medicine, University of Central Florida, College of Medicine, Orlando, FL
Founder, Institute for Hormonal Balance, Orlando, FL
Member, AMMG Conference Planning Committee
Growth hormone is an essential hormone in lowering body fat, improving on lipids, keeping muscles healthy and improving on bone density. Adult growth hormone deficiency symptoms will be reviewed and the association of higher mortality with growth hormone deficiency. Unfortunately the treatment with recombinant human growth hormone is not covered under most insurance plans and it is also cost prohibitive for most people. There is an alternative to the expensive recombinant human growth hormone most commonly used for boosting IGF-1 and has the advantage of inducing all five of the hGH isoforms rather just the one that is found in the synthetic form. CJC-1295, Ipamorelin, GHRP-6, Teslomorelin and others are peptides that have been shown to help improve IGF-1 levels. In addition the diagnosis of adult onset growth hormone deficiency and the use of human Growth Hormone will be reviewed.
12:00 – 1:30 pm Lunch Break
12:00 – 1:00 pm The Most Common Dysfunctions of the Standard American Gut in Chronic Illness
Presented by Kiran Krishnan
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs
1:30 – 2:15 pm Use of Fitness & Exercise in an Age Management Medicine Practice
Mary Corry, R.N.
Medical Education Specialist, Worldlink Medical, Salt Lake City, Utah
Member, AMMG Conference Planning Committee
Member, Sigma Theta Tau International Honor Society of Nursing
One of the key components to Age Management Medicine is exercise. During this presentation, we will discuss the benefits of exercise and how to build an effective exercise program for beginner and advanced patients.
2:15 – 3:00 pm Compliance with Federal and State Regulations as You Begin Your Age Management Practice
Paul D. Werner, Esq.
Member, Buttaci, Leardi & Werner Law Firm, Princeton, NJ
Recognize when relevant Federal and State regulations are implicated within your age management practice and measure and evaluate necessary steps to ensure compliance with these statutes and regulations. This workshop will focus on one essential element; compliance as an ongoing process. Compliance with Federal and State regulations depend entirely upon a provider’s willingness to be motivated, alert, and self-critical. Compliance and compliance plans are a risk management tool that should address each and every area of potential exposure. Good faith efforts to focus on and implement thorough compliance mechanisms evidences a provider’s commitment to compliant and ethical practice and therefore undermines any allegation of intentional malfeasance. Compliance with Federal and State regulations is not only important when beginning a new practice, but is an essential element to the ongoing success of that practice. Continual monitoring of compliance “hot spots,” which requires a comprehensive understanding of the relevant regulatory framework, helps identify issues before they escalate into problems that could result in liability.
2:30 pm Exhibits Open
3:00 – 3:40 pm Break / Visit Exhibits
3:40 – 4:30 pm Age Management Medicine Clinical Recommendations for Diet and Weight Loss
Dushyant Viswanathan, M.D., ABIM, ABoIM, AACE
Medical Director, The Columbia Center for Integrative Medicine, Columbia, MD and Woodland Hills, CA
Obesity has gained epidemic proportions and is now the leading cause of chronic medical illnesses that occur as we age. Correcting obesity should therefore be paramount for every physician who practices age management medicine. Old concepts of weight-loss, such as low-fat diets, have been shown to actually increase cardiovascular risks. The Mediterranean diet has been proven to have beneficial effects on health but, per se, may not provide a good option for losing weight. Newer concepts such as higher fat diets, ketogenic diets and fasting mimicking diets have accumulated a plethora of evidence that suggests these appear to be preferred options for patients to lose weight. Physicians should consider this new evidence when recommending weight-loss options.
4:30 – 5:30 pm Assessing the Age Management Patient
Michale “Mickey” Barber, M.D.
CEO & CMO, Better Life Carolinas, Charleston, SC & Charlotte, NC
This lecture will focus on the many aspects of a patient’s health and fitness that should be evaluated as part of the initial assessment. This assessment should provide the patient and clinician with information about the patient’s health and disease history, nutritional patterns, sensitivities and supplement history. An assessment of fitness, strength and balance are also considered to be essential to setting up goals for a healthy aging program. The measurement and interpretation of key aging biomarkers including hormones will be discussed. The impact of stress on our health and longevity is well known and should also be assessed from day one of beginning an age management program. Attendees should leave this lecture with a good understanding of a basic as well as advanced age management assessment protocol.
5:30 – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Thursday, November 7th

CBD, THC and Cannabis Derived Therapies for Age Management Medicine

Over the past decade, the medical use of marijuana, CBD, THC, and other derivates of cannabis has increased exponentially in the U.S. Well over half the states have enacted laws in some form to allow physicians to prescribe marijuana medically—and by 2021, all 50 states may have laws allowing medical marijuana in some capacity. AMMG takes no political position on such uses—we are medical educators. That said, it’s clear a definite gap exists in medical education for physicians/healthcare professions who treat a rising patient base that is requesting or inquiring about medical marijuana for a gamut of disorders. AMMG stands in that gap to better educate and inform physicians so they are qualified to respond to this changing medical climate.

Time
Presentation
7:00 – 7:45 am Compounds Used in BHRT with PDE-5 Inhibitors
Presented by Dr. Eugene Shippen & David J. Metayer
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 – 9:00 am Scientific Rationale for the Use of Marijuana, CBD, and other Derivatives for Use as Clinical Applications
Derrick DeSilva, Jr., M.D.
Teaching Faculty, JFK Medical Center, Edison, NJ
Co-Chair, Department of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
CBD (Cannabidiol) is emerging as a powerful supplement with a significant effect on our body’s endocannabinoid system. The endocannabinoid system has been shown to have a strong effect on the inflammatory, immune, cognitive and motor systems of the body. Cannabidiol (CBD) is one of over 80 cannabinoids, natural compounds found in industrial hemp. The endocannabinoid system (ECS) is perhaps the most important physiologic system involved in establishing and maintaining human health. Endocannabinoid receptors are found throughout the body: in the brain, organs, connective tissues, glands, and immune cells. In each tissue, the cannabinoid system performs different tasks, but the goal is always the same: homeostasis or balance. CBD has shown promising results in independent research and studies as a treatment for a variety of conditions including antiemetic, anticonvulsant, antipsyotropic, anti-inflammator, antioxidant, anti-tumoral, anti-anxiolitic/antidepressant, and more. We will review the basic science of CBD and the scientific evidence supporting the many applications of CBD along with the clinical applications of Full Spectrum Hemp Oil (CBD) that can be used in your medical practice.
9:00 – 10:00 am Role of DEA and FDA in Use of CBD and THC
Paul D. Werner, Esq.
Member, Buttaci, Leardi & Werner Law Firm, Princeton, NJ
This workshop will address the changing landscape relative to the use of cannabis-derived products, such as CBD oil and other CBD products. Federal statutes, such as the Agricultural Improvement Act of 201 8(the “2018 Farm Bill”), the Federal Food, Drug, and Cosmetic Act (the “FD&C”), and FDA and DEA guidelines relative to the classification of cannabis-derived products intertwine to create a complex regulatory framework within which health care providers must operate. Understanding the various regulatory schemes in place and how cannabis-derived products can be used and marketed is fundamental to compliance with federal law and relevant agency guidelines. This workshop will identify the relevant regulatory guideposts and provide direction as it relates to compliance with and understanding of this changing landscape.
10:00 – 10:15 am Break
10:15 – 11:15 am Alzheimer’s Disease/Dementia and Cannabinoids—Is It an Option?
Joseph Rosado, M.D., MBA
Medical Director, Coastal Wellness Centers, DeLand, FL
Advisory Board Member, Cannabidiol Life
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. Presently, it now ranks as the 6th leading cause of death in the United States. There are two types of onset of AD with various causes, classifications and stages. Medical cannabis is one of the natural treatments that people, especially baby boomers, are turning to for symptom relief and disease treatment; it [medical cannabis] has proven to be beneficial for many chronic, degenerative conditions, including Alzheimer’s disease. In this presentation, Dr. Joseph Rosado will discuss, what Alzheimer’s disease is, how many people are affected by and die as a result of it, what causes it, how it’s treated “conventionally”, what is in the scientific literature regarding Alzheimer’s disease and medical cannabis and how to manage/treat AD patients with medical cannabis.
11:15 am – 12:00 pm CBD for Autoimmune and Inflammatory Diseases
Soyona Rafatjah, M.D.
Medical Director and Co-Founder, PrimeHealth
With the growing prevalence of autoimmune diseases in the world, there is a huge need for therapies that improve and restore balance to immune function, without suppression. Cannabinoids and hemp oil have shown promising results for the improvement of autoimmune and inflammatory conditions, through mechanisms including the activation of CB1 and CB2 receptors. Positive preliminary data exist supporting the use of cannabinoids for the improvement of MS, IBD, mast cell activation syndrome, Lou Gehrig’s disease, arthritis, scleroderma, and type 1 diabetes.
12:00 – 1:30 pm Lunch Break
12:00 – 1:00 pm The Most Common Dysfunctions of the Standard American Gut in Chronic Illness
Presented by Kiran Krishnan
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs
1:30 – 2:15 pm Public Enemy Number One: Osteoporosis. Treatment with CBD Oil
Eric I. Mitchell, M.D., MA, FACPE, CPE
CEO/Medical Director, Hemp Commodity Industries, LLC
Medical Director, Community Greenhouse, LLC
Clinical Director, Pine Tree Alternative Pain Clinic, Bangor, ME
Vitamin D’s reputation for helping bone porosity took a hit in JAMA, April 2018 from the U.S. Preventive Services Task Force. This independent group which makes health policy recommendations concluded that when it comes to preventing fractures, there is not enough evidence to recommend for or against supplementation for Vitamin D.  Because of the longevity of the boomers, osteoporotic fractures are an increasingly important cause of morbidity and mortality in the United States. Within 1 year of suffering a hip fracture, a high percentage of patients are unable to walk independently, more than half require assistance with activities of daily living, and 20% to 30% of patients will die. Approximately 2 million osteoporotic fractures occurred in the United States in 2005, and the annual incidence is projected to increase to more than 3 million fractures by 2025. This window of opportunity, which has been in plain sight, however, has been restricted from applying modern science to a botanical known as Cannabis sativa L. One of the compounds derived from this plant has been studied around the world as America has been in a prohibition for the last 39 years. The Farm Bill of 2018 will now allow us to study the benefits of the cannabinoid, cannabidiol, and its effects on bone density.
2:15 – 3:00 pm The Endocannabinoid System and Unique Female Issues
Felice L. Gersh, M.D.
Integrative Medical Group of Irvine, CA
Retired Assistant Clinical Professor of OB/GYN, Keck-USC School of Medicine
Consultative Faculty, Fellowship in Integrative Medicine, University of Arizona School of Medicine
It is often forgotten that the prime directive of life is successful reproduction, and few understand the critically important role played by the newly discovered Endocannabinoid System, in support of reproductive health. The Endocannabinoid System is an all-encompassing lipid signaling complex linking female reproduction with the collaborative functions of cognitive, emotional, metabolic, and immune health, ensuring optimal female fertility when all is in homeostatic balance. This lecture will provide an overview of the myriad ways in which the endocannabinoid system supports female reproduction and overall health and will review the female disease states which manifest with endocannabinoid system dysregulation. Health care providers will be provided the tools to enhance the health of the female endocannabinoid system and when needed, to safely and appropriately utilize plant-based cannabis to optimize female health and fertility.
2:30 pm Exhibits Open
3:00 – 3:40 pm Break / Visit Exhibits
3:40 – 4:35 pm CBD and THC as a Treatment for Neurological Disease
Michael Lewis, M.D., MPH, MBA, FACPM, FACN
Colonel (Retired), U.S. Army
Private Practice, Potomac, MD
There continues to be growing interest in the medicinal uses of cannabis for health maintenance and certain medical indications. In particular, the use of CBD for cognitive/brain health is rapidly growing, both in market demand and scientific research. CBD has application in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurogenerative diseases such Alzheimer’s Disease, Parkinson’s Disease, and Chronic Traumatic Encephalopathy (CTE). Dr. Lewis will explore the science behind the endocannabinoid system (ECS), particularly in the brain, and the interaction of our endogenous cannabinoids and phytocannabinoids have with our ECS. Additionally, Dr. Lewis will discuss his clinical experience using cannabis phytocannabinoids, particularly the value of using CBD for anxiety, depression, and after head injuries.
4:35 – 5:30 pm Full Spectrum Cannabis: Benefits Beyond THC & CBD
Betty Wedman-St. Louis, Ph.D., RD
Assistant Professor, New York Chiropractic College
Adjunct Professor, Everglades University, Sarasota, FL
Adjunct Professor, South University-Tampa, FL
There is a lot more to cannabis than THC and CBD, its predominant cannabinoids. Terpenes are the fragrant oils that give cannabis its aromatic diversity. Flavonoids provide synthesis of antioxidant properties as potent inhibitors of cyclooxygenase enzymes and prostaglandin E2 production. The “entourage effect” identified by EB Russo, M.D. in 2011 offers medicinal properties beyond the efficacy of single cannabinoid effectiveness or a single CBD remedy for a specific disorder like seizure management. Whole plant medicine combines cannabinoids, terpenes and flavonoids to provide pain, sleep, gastro-intestinal, mood and behavior, and neurological benefits. The analysis of terpenes allows patients to determine correct strains for their symptom management. Of the more than 200 terpenes and 29 flavonoids found in cannabis, six primary terpenes and five flavonoids are key to selecting full spectrum cannabis products.
5:30 – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Thursday, November 7th

Office Based Aesthetics for the Age Management Clinician*

In response to attendee requests for information on aesthetic protocols and treatments which are office based and can be done by non-board certified Age Management Clinicians either full time or as an adjunct to their existing practice, AMMG presents this track in conjunction with the Advanced Aesthetic Education Group. The decision not to accredit this track was made so that attendees could be provided with business tools as well as the science and medical information necessary to implement these procedures. The goal is not to make this track commercial but to give speakers in this niche area the leverage to openly discuss procedures and answer questions that could be severely restricted in an accredited environment.

In conjunction with the Advanced Aesthetic Education Group

* Track is Non-CME

Time
Presentation
7:00 – 7:45 am Compounds Used in BHRT with PDE-5 Inhibitors
Presented by Dr. Eugene Shippen & David J. Metayer
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 – 9:00 am Advanced Dermal Fillers
Josie L. Tenore, M.D., MSc., BCIM
Clinical Physician & Owner, Medical Spa, Highland Park, IL
Physician Advisor, Executive Health Recourses, Philadelphia, PA
Clinical Physician, Lake County Public Health Dept.
Academic Family Physician and Assistant Residence Director, McGraw Medical Center of Northwestern University, Dept of Family Medicine
As the population ages, there has been increased interest in non-surgical aesthetic treatments. As our knowledge of medicine, biology, and physics has advanced, we now know much more about the anatomy of facial aging. While facial aging follows a general pattern, the plan for treatment needs to be customized to the individual. This course is intended to review the aging process, help the practitioner assess the face as a three dimensional structure, and educate them to develop a strategic plan for restoration of youth and beauty for both genders. The course will review all the currently available dermal fillers and volumizers and help the provider chose the filler/volumizer that is best for the patient. The provider will also learn how to perform a customized consultation for the patient and provide them with appropriate knowledge to be able to give informed consent for treatments.
9:00 – 10:00 am Office Based Stem Cell Therapy
H. William Song, M.D.
Founder and CEO, Omni Aesthetics, Oakland, NJ
Founding Member, American Academy of Stem Cell Physicians
Faculty Instructor, Cellular Medicine Association and Advanced Aesthetics Education Group
The demand for stem cell therapy is currently outpacing the supply of competent physicians capable or knowledgeable enough to safely and ethically deliver this promising new treatment. Multiple sources of cellular therapy fall under the broad umbrella of what is being called “stem cells,” making it very difficult for patients as well as physicians to navigate this rapidly evolving field. In this presentation, the currently available regenerative therapies will be discussed. Autologous sources such as bone marrow and adipose tissue will be compared with allograft sources such as amniotic and umbilical cord tissue. Basic stem cell terminology and updates on the current regulatory climate will be presented for the practitioner looking to enter the field of stem cells and regenerative medicine.
10:00 – 10:15 am Break
10:15 – 11:15 am Exosomes: Aesthetic Cellular Therapy Without the Cell
H. William Song, M.D.
Founder and CEO, Omni Aesthetics, Oakland, NJ
Founding Member, American Academy of Stem Cell Physicians
Faculty Instructor, Cellular Medicine Association and Advanced Aesthetics Education Group
There has been a significant amount of controversy regarding the effects of testosterone therapy on heart disease. This has been a major topic in our national media as well as the medical community. Unfortunately, the reports have led to a significant amount of misinformation as well as uncertainty both in the minds of doctors and patients. Does testosterone therapy lead to heart disease? Is testosterone therapy safe? Is an individual at risk because he or she was on testosterone therapy in the past? This lecture will offer a review of the medical literature and allow the physician and the patient to make the correct and informed decision regarding testosterone therapy.
11:15 am – 12:00 pm Aesthetic Protocols and Pearls to Use in Treating Patients of Color
Agnes Green, M.D.
Medical Director, Ageless and Evergreen, Tampa Bay, FL
To review common aesthetic procedures and special consideration(s) for treating skin of color.
12:00 – 1:30 pm Lunch Break
12:00 – 1:00 pm The Most Common Dysfunctions of the Standard American Gut in Chronic Illness
Presented by Kiran Krishnan
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs
1:30 – 2:30 pm Light Emitting Diodes: Fact or Fiction
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic, Redlands, CA
Medical Advisor, Rejuvenate Image Restoration, Refine and AQ Skin Solutions
LED or Light Emitting Diodes were first used in a NASA program for healing. How do we choose the right equipment and what are the key factors to look for? What do we use it for and what are the protocols for each treatment? Does price reflect quality? What wavelengths are needed and how many photons per square centimeter? All these questions will be answered in this lecture, as LED is rapidly becoming a vital part of the aesthetic menu and is an inexpensive addition to the physician office based protocols.
2:30 – 3:15 pm Use of Amniotic Fluid for Aesthetics
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic, Redlands, CA
Medical Advisor, Rejuvenate Image Restoration, Refine and AQ Skin Solutions
This session will discuss clinical applications of amniotic fluid in regenerative and aesthetic procedures. How do we combine all the new and exciting procedures, including PRP, exosomes and amniotic fluid, and what do we charge?
2:30 pm Exhibits Open
3:15 – 3:45 pm Break / Visit Exhibits
3:45 – 4:45 pm Microneedling with Hands-on Procedure – Lecture & Demonstration
Marie Piantino, L.E.
President, Aesthetic Education Group, LLC
Founder, American Academy of Medical Microneedling
Nadia Bixler, L.E.I.
Medical Esthetician, Bobbi Bullock Medical Esthetics, Boise, ID
Microneedling, CIT (collagen induction therapy) or vertical needling is a method of using an automatic device to perforate the tissue on the face and/or body. Tiny “micro” needles are used to create microchannels in the tissue which start a controlled wound healing action. This healing action is a natural process the body goes through after injury. Microneedling creates hundreds of thousands of microchannels in the dermas which heal themselves over the next several weeks. These tiny perforations also aid in product absorption, therefore peptides, hyaluronic acids & PRP (Platelet Rich Plasma) is topically applied during the microneedling process. Microneedling is gaining popularity in the medical aesthetic field because it can treat a variety of skin indications, and it is a high profit, non-invasive procedure that can be delegated to a nurse, MA or aesthetician.
4:45 – 5:30 pm The Latest Equipment and Services for Your Success: Increase Your Sales and Patient Satisfaction for Your Office Based Practice or Spa
Marie Piantino, L.E.
President, Aesthetic Education Group, LLC
Founder, American Academy of Medical Microneedling
Understand the ideal and profitable medical-spa setting along with the latest trends in equipment in the industry today. Update your knowledge on lifting devices, infusion devices, IPL, ultrasound, radio frequency, lasers, and LED. Learn the benefits of each device and the latest protocols. Be ahead of your competition. EVERYTHING YOU NEED TO KNOW TO INCREASE YOUR BOTTOM LINE! Offer maximum results with minimum downtime.
5:30 – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Thursday, November 7th

Advanced Diagnostic and Treatment of Neuro Recovery Protocols for Traumatic Brain Injury - Day 2

Time
Presentation
7:00 – 7:45 am Compounds Used in BHRT with PDE-5 Inhibitors
Presented by Dr. Eugene Shippen & David J. Metayer
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by University Compounding Pharmacy
8:00 – 9:30 am Laboratory of Traumatic Brain Injury
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
9:30 – 10:15 am Alzheimer’s Disease and Hormones
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
10:15 – 10:30 am Break
10:30 am – 12:00 pm Addressing Neuroinflammation with an Evidence-Based Nutraceutical Approach
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
12:00 – 1:30 pm Lunch Break
12:00 – 1:00 pm The Most Common Dysfunctions of the Standard American Gut in Chronic Illness
Presented by Kiran Krishnan
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Microbiome Labs
1:30 – 3:00 pm Putting it all Together in Treatment with Core Case Discussion
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
2:30 pm Exhibits Open
3:00 – 3:45 pm Break / Visit Exhibits
3:45 – 5:30 pm Advanced TBI Case Presentation and Discussion
Mark L. Gordon, M.D.
Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
Consultant – Medical Board State of California
Medical Director of Education, Access Medical Laboratories, Jupiter, FL
Member, AMMG Conference Planning Committee
5:30 – 7:00 pm AMMG Welcome Reception
Open to all conference attendees, spouses, and guests
Held in Conference Networking and Exhibits Center

Friday, November 8th

General Session Curriculum

Time
Presentation
7:00 – 7:45 am Why Weight Loss and Lipo Laser Should Be Part of Your Age Management Business
Presented by Dr. Kimball Lundahl
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by Healthy Habits
8:00 – 8:05 am Opening Remarks
8:05 – 8:30 am Presentation of the Alan P. Mintz, M.D. Award for Clinical Excellence in Age Management Medicine
8:30 – 9:15 am The Over/Mis-Diagnosis of Depression/Anxiety/Bipolar/Mood Disorder and the True Issue Being Hormonal Decline
Jill E. Stocker, D.O.
President, Jill E. Stocker, D.O. PC
In 2017, the WHO listed depression as the leading cause of illness and disability worldwide. We’re so emotionally constipated as a society. There’s so much fear and shame around expressing emotions or that maybe you feel “off”. The “I’m fine” mask needs to come off! You deserve a whole SPECTRUM of emotions! We should celebrate, not medicate! All too often patients are over or mis-diagnosed with depression or mood disorder, and the underlying issue is truly hormonal imbalance. They are told that their lab values are “normal” and that their symptoms are “just part of aging”, “in their head” or given a label of anxiety/depression/mood disorder/bipolar disorder. When patients are effectively LISTENED to, and a common language of symptoms is established, people are able to go from surviving to THRIVING, with hormonal and life optimization.
9:15 – 10:00 am Sexual Security: Helping Your Patients Maintain Lifelong Passion & Performance
Kathryn Retzler, N.D.
Private Practice, HormoneSynergy Clinic LLC
Sexual expression is a fundamental human need. Sexual interest and frequency may decline with age due to many factors including low libido, performance issues, anorgasmia, or illness. This lecture will discuss types of sexual issues and a strategy to enhance your patients’ sexual security.
10:00 – 10:30 am Break / Visit Exhibits
10:30 – 11:15 am How Modern Medicine is Slowly Killing Women: Becoming Part of the Solution and Not the Problem
Angela DeRosa, D.O., MBA, CPE
Founder & President, Hormonal Health Institute, Scottsdale, AZ
In 2002, the Women’s Health Initiative JAMA article was a “shot” which was heard around the world. This changed the landscape of women’s hormonal health and some might argue irreparably harmed women’s health for decades to come. “Hormones were killing women” was the mantra, but unfortunately this “shot” was inappropriately aimed and highly inaccurate. However, the damage was done and this left hormonal and women’s health experts with a tough road to climb in changing the paradigms related to the true data and understanding as it comes to women’s health, hormones and its impacts on long-term health. Unfortunately, modern medicine through its best intentions are slowing killing women with pharmaceuticals and other medical “advances” with disregard to the root causes of what drives women to seek help from their providers. We are slapping band-aids on hormonal symptoms when balancing a women’s hormones would get to the cause and help our patients live longer and healthier lives. This lecture will review the historical aspects of the WHI and the harms it created for women and more importantly provide you the true data to become part of the paradigm shift and give you solutions to help our female patients live longer and healthier lives.
11:15 am – 12:15 pm Viagra Surprise: The Blockbuster Age Management Benefits of the PDE5 Inhibitors
Eugene Shippen, M.D.
Author, “The Testosterone Syndrome”
There is one blockbuster treatment, that is by far the most cardio-protective treatment to date, but has been completely ignored by cardiologists and mainstream doctors. One recent article shows 81% reductions in all cardiovascular events (MI, revascularization, heart failure or death) in 43,000 men with established CVD who use PDE5 inhibitors regularly! There are even greater reductions in overall mortality if PDE5 inhibitors are combined with other treatments (statins and testosterone) in 857 diabetic men over 3.8 year periods – 60% mortality untreated vs <3% mortality if treated with all three treatments! Amazingly, there are other major benefits that include improved brain function and repair after stroke and possibly prevention for aging dementia. Additional major benefits include treatment of pulmonary hypertension and heart failure. One of the key mechanisms of action is the increased release of endothelial stem cells that populate the major organs. This effect may be the major reason for diverse health benefits way beyond the sexual benefits most doctors see as the major function of this category of drugs. The PDE5 inhibitors, like Viagra and Cialis, have a growing peer reviewed literature that outlines these many benefits. These references will be presented. I believe that the protective health benefits are the biggest breakthrough in medical history on CVD and other health protective benefits and are being ignored because of the limited focus on sexual benefits!
12:15 – 1:30 pm Lunch Break / Visit Exhibits
12:15 – 1:15 pm How Beta-Alanine Supplementation Supports Healthy Aging Via Supporting Cognitive Function and Muscle Health
Presented by Jay Hoffman, Ph.D., FNSCA, FACSM
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by CarnoSyn® Brands
1:30 – 1:45 pm Why Undergo Certification in Age Management Medicine
Derrick DeSilva, Jr., M.D.
Teaching Faculty, JFK Medical Center, Edison, NJ
Co-Chair, Department of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
1:45 – 2:30 pm Integrative Medical Approach for Wellness and Vibrant Aging
Beatriz Rodriguez Olson, M.D., FACP
Former Assistant Clinical Professor of Medicine, Yale School of Medicine
Associate Staff, Yale Endocrinology Group
Private Practice, Endocrinology, Middlebury, CT
During this presentation, participants will learn about the clinical thought process behind an integrative endocrine approach to age management using one or two real cases from Dr. Olson’s practice. The ultimate goal is to enhance quantity and quality life, by delaying or preventing diseases and attitudes of the aging, using a holistic mind-body approach. This presentation will focus on basic cornerstones and routines that maintain vibrant health, including need for self-monitoring, hormone management, and integration of patient-specific biology to supplementation, motivation and personal needs.
2:30 – 3:15 pm The Estrogen, Progesterone, Testosterone Link: Aging Men and Women
Benjamin S. Gonzalez, M.D.
Medical Director, Atlantis Medical Wellness Center, Silver Spring, MD
A detailed look at the connection between estrogen, progesterone, and testosterone in both women and men in aging. A discussion and literature review of how these three hormones confer a sense of potency, power, and self esteem in both men and women. A discussion of how the Hypothalamic-Pituitary-Adrenal axis plays a role in the decline and maintenance of these three hormones. Case studies will be reviewed for emphasis.
3:15 – 4:00 pm Break / Visit Exhibits
Point / Counterpoint Sessions on Controversial Issues in Age Management Medicine
4:00 – 4:40 pm Exosomes vs. Stem Cells
George Shapiro, M.D.
Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
Founding Partner, Cenegenics, New York City
Member, AMMG Conference Planning Committee
William Kapp III, M.D., MS, FAAOS
Founder, Chairman/CEO, Longevity Bioimaging/Landmark Hospitals, Naples, FL
4:40 – 5:30 pm Estrogen vs. No Estrogen
Neal Rouzier, M.D.
Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
Rob Kominiarek, D.O., FACOFP
Member, AMMG Planning Committee
Director, ReNue Health, Springboro, OH
Assistant Clinical Professor, Ohio University College of Osteopathic Medicine

Saturday, November 9th

General Session Curriculum

Time
Presentation
7:00 – 7:45 am Regeneration and Age Management Protocols for Brain Health
Presented by Sheldon E. Jordan, M.D., FAAN
Open to all attendees and includes a complimentary breakfast
Non-CME symposium sponsored by Kimera Labs
8:00 – 8:45 am Utilizing Genomics, Wearable Data and Technology to Create Data Driven Health
Daniel L. Stickler, M.D.
Co-Founder, Apeiron Center for Human Potential, Austin, TX
CME & Co-Founder, Apeiron Academy Medicine Education and Technology
We are in a world where everything is becoming highly reliant on data. Clinicians have been slow to adopt this new paradigm. In this talk we will discuss how to utilize precision genomic data, wearable technology data and other measurable tech devices that can create ideal health plans and interventions.
8:45 – 9:30 am Empowerment through Knowledge: New Insights into Utilizing Genetic Analysis to Optimize “How to Live”
Dennis A. Goodman, MB ChB, FACC, FACP, FCCP, ABIHM
Clinical Professor of Medicine, New York University School of Medicine
Director of Integrative Medicine, New York University School of Medicine
Department of Preventive Cardiology, New York University School of Medicine
Professor of Medicine, University of Cape Town, South Africa
The purpose of this lecture is to understand the difference between genetics, genomics, and epigenetics as applied to clinical practice. As practitioners, it is not only important to counsel our patients about their “specific” genetic variations, but also to help them understand what affects their genetic “expression” through interaction with their environment including diet and lifestyle. Being familiar with the most “cutting edge” testing in the field of genetics will help the practitioner be able to focus on what is important for each patient on an individual basis. And instead of concentrating on genetics that show an “increased risk of dying” we will focus on how to use the genetic information, interpretation, and application to show a person “how to live optimally”!
9:30 – 10:15 am Genetics, Estrogen, and Precision Medicine: One Size DOES NOT Fit All
Rebecca Murray, APRN, FNP-BC, CDE
Endocrine Nurse Practitioner, Institute for Hormonal Balance, Orlando, FL
Medical Director, Ward-Murray HealthCare Consulting, Groton, CT
Scientific Advisory Board, Designs for Health
In this lecture, we will explore the revolutionary new world of being able to access our patients genetic profiles and to identify “single 
nucleotide polymorphisms” that influence the production, metabolism, detoxification, and elimination of estrogen along with estrogen receptor modulation. We will also place special emphasis on the newest research in the area of “risk reduction” of estrogen-related health problems in both men and women.
10:15 – 10:45 am Break / Visit Exhibits
10:45 am – 11:30 am Matching DNA with Interventions to Resolve Obesity and Increase Longevity
Elliot Dinetz, M.D., ABFM
Timeless Health, Miami, FL
As we continue to see the development and utilization of Genomics entering clinical practice, this presentation will examine what this will mean for patients now and in the future. We will review the definition of Genetics, Genomics, and what Single Nucleotide Polymorphisms (SNPs) are and how they’re helping better the way we practice medicine. With the future of healthcare being personalized medicine, this technology will continue to help enable us to tailor medical care to the individual and maximize healthspan. SNPs, or our genetic variants, may predispose an individual to health risks but they too may prove beneficial. In reviewing some of the more well-studied SNPs we will dive into how to utilize this tool as part of a systems biology approach for advanced prevention. Additionally, in understanding patients’ metabolic needs, we may customize an ideal lifestyle such as exercise requirements, appropriate nutrition, and even alerting of potential food sensitivities which can cause occult inflammation. By alleviating the need for trial and error we can limit patient suffering and accelerate optimal health. With this technology we may improve upon precision care to enable physicians to best target chronic conditions. By identifying susceptibility towards things such as histamine accumulation, high risk variants for clotting disorders as well as cardiovascular disease, and how certain people are more prone to inflammation, we may more effectively treat their root cause. With an integrative approach we may help improve while even reverse conditions like IBS, migraines, and cardiovascular disease. This physician assist tool may help achieve results that go far beyond the reactive focus in conventional care and allow Primary Care to take control of health care. This is the epitome of personalized medicine.
11:30 – 12:15 pm Natural Aromatase Inhibitors
Derrick DeSilva, Jr., M.D.
Teaching Faculty, JFK Medical Center, Edison, NJ
Co-Chair, Department of Complimentary Medicine and Senior Attending Staff, Raritan Bay Medical Center, Perth Amboy, NJ
One of the most dangerous enemies to men when it comes to boosting testosterone is the Aromatase enzyme. This destructive enzyme’s main role is to convert testosterone into the female hormone estrogen. It goes without saying that men who want to keep their testosterone at optimal levels need to take measures to keep this enzyme at reasonable levels because this will ensure that they are protecting testosterone and not allowing it to be converted into estrogen. Of course, we can control aromatase activity with the use of prescription medications, but what about the potential nutrient depletion and the side effects from the prescription drugs. There are “natural aromatase inhibitors” that have well documented effects without the side effects and have the potential for “side benefits” vs. side effects. We will review these natural aromatase inhibitors along with some of the other potential side benefits that these natural compounds process.
12:15 – 1:30 pm Lunch Break / Visit Exhibits
12:15 – 1:15 pm

Live The Dream: Secrets for Impact, Influence & Income
Presented by Clint Arthur
Open to all attendees and includes a complimentary lunch
Non-CME symposium sponsored by Celebrity Entrepreneur

1:30 – 2:15 pm Hormones and Fascia: Why Perimenopausal Women Ache and What To Do About It
Angeli Maun Akey, M.D., FACP, ABIHM/ABOIM, ABAARM
Courtesy Assistant Clinical Professor, University of Florida College of Medicine, Gainesville, FL
Founder, Ageless Medical Solutions and North Florida Integrative Medicine
Co-Founder, FIRRIMup Doctors
The fascia, more properly termed “fascial system”, builds a three-dimensional continuum of soft, collagen-containing, loose and dense fibrous connective tissue that permeates the body and enables all body systems to operate in an integrated manner. The basics of the fascial system at a microlevel (molecular and cellular responses) to the macrolevel (mechanical properties) will be reviewed to understand myofascial pain. Epidemiologic, clinical and experimental findings point to sex differences in myofascial pain, where women tend to experience pain more than men. Newer research has found there is hormone receptor expression in human fascial tissue; specifically, relaxin receptor 1 (RXFP1) and estrogen receptor-alpha (ER alpha). It is theorized that one of the stimuli for sensitization of fascial nociceptors could come from the hormonal factors estrogen and relaxin that are involved in extracellular matrix and collagen remodeling. Thus, it would follow that bioidentical hormone replacement therapy (BHRT) would contribute to restoring baseline function to aging myofascial tissue in the perimenopausal/ menopausal woman. This discussion will review current understanding of the myofascial components of pain transmission in the perimenopause and menopause stage of a woman’s life and provide an approach to bioidentical hormone replacement therapy to address these concerns.
2:15 –3:00 pm Treatments for Hyperthyroidism; rT3 and Hypothyroidism; TSH, Treat the Patient not the Lab Result
Jonathan V. Wright, M.D., N.D. (hon)
Private Practice, Tahoma Clinic, Tukwila, WA
This presentation is based on research published in 1980 by the Endocrine-Metabolic Service of Walter Reed Army Hospital, which told us that iodine and lithium rapidly controls thyrotoxicosis. The presentation provides detailed case examples including supplementation amounts, testing, and other recommendations until resolution of condition. The next segment of the lecture discusses the relationship of elevated rT3 with toxic metals and how to recognize the problem. The final section deals with TSH, investigating whether or not TSH should be relied on as an indication of thyroid function. Discussion on the relationship between TSH and TRH, and a few of the other non-thyroidal functions of TRH are provided.
3:00 – 3:45 pm Break / Visit Exhibits (exhibits close 3:45 pm)
3:45 – 4:45 pm Enteroimmunology & Endocrinology: How Dysbiotic Gut Inflammation leads to Hormone Imbalances, and How Reversing Them is the Key to Resolving Chronic Illness
Dushyant Viswanathan, M.D., ABIM, ABoIM, AACE
Medical Director, The Columbia Center for Integrative Medicine, Columbia, MD and Woodland Hills, CA
Gut dysbiosis is associated with inducing a chronic inflammatory state that affects every organ and is implicated in the pathogenesis of multiple chronic conditions in the scope of internal medicine. Here we articulate relevance, diagnostic/therapeutic concerns of translational mucosal immunology (“Enteroimmunology”) and articulate the impact on measured cortison secretion patterns as demonstrated by 24 hour salivary cortisol testing. Inflammatory cytokines stimulate cortisol secretion, and over time, an endocrinopathy develops: dysfunctional diurnal cortisol secretion, depletion of beneficial hormones such as testosterone, DHEA, progesterone, pregnenolone, thyroid hormone, and sometimes estrogens (although elevations of estrogens due to impaired excretion is more common) occur. These physiologic events are implicit in the process of aging. We will describe treatment approach and cases featuring gut microbiome repair and restitution of optimal hormone levels as essential to lessening physiologic/cellular aging and inflammation.
4:45 – 5:30 pm The Little Explored Link Between Insulin Resistance and Autoimmune Disease
Ritamarie Loscalzo, BA, MS, D.C., DACBN, CCN
Private Practice, Austin, TX
Insulin resistance can both cause and be caused by an autoimmune condition. In this presentation, I will delve deep into the connections between: Insulin resistance is becoming epidemic; Type 2 diabetes is on the rise; LADA – latent autoimmune disease of adulthood is common, and very much overlooked by a lot of medical practitioners. Insulin resistance and inflammation, the production of auto-antibodies and the effect on blood sugar control, and how all of the complications can be prevented by early detection of insulin resistance – what I term pre-insulin resistance. “Pre-insulin resistance” can be detected decades before it is clinically recognized, and as nutrition practitioners, we are uniquely positioned to coach our clients on how to prevent, detect and reverse it naturally.
5:30 – 6:15 pm The Latest on Stem Cells & Exosomes Safety Guidelines
Presented by A.J. Farshchian, M.D.
Non-CME lecture sponsored by The Center for
Regenerative Medicine
7 – 9:00 pm

SPECIAL SCREENING EVENT

QUIET EXPLOSIONS: Healing the Brain
Written and directed by EMMY Award-winner Jerri Sher
Every year thousands of people’s lives are impacted and ruined by Traumatic Brain Injury (TBI). Now there is hope. Through the Warrior Angels Foundation and Dr. Mark Gordon, vets and civilians are healing and returning to a normal and full life.This includes such well-known people as Mark Rypien, Super Bowl XXVI MVP; and Anthony Davis, the infamous “Notre Dame Killer” running back from USC, along with big wave Pro Surfer, Shawn Dollar. Joe Rogan, Podcast Host is featured throughout the film. See the amazing story that could change the life of someone you love! EMMY Award-winner Jerri Sher directed and produced this film after being inspired by the best selling book “TALES FROM THE BLAST FACTORY” by Green Beret, Andrew Marr and his brother, Apache Pilot, Adam Marr.AMMG will present a screening of the full length movie as a public service for Veterans and TBI Patients. This event will take place in the Conference General Session Room and is open to all conference attendees, their families and guests. In addition AMMG will invite any interested Physicians or Healthcare Professionals, Military Veterans, Active Military, TBI Patients, Sports Professionals etc.
View the Trailer.

Sunday, November 10th

General Session Curriculum

Time
Presentation
7:00 – 7:45 am TBD
8:00 – 8:45 am Yoga Therapy for Age Management Medicine
Elaina Heather Viswanathan, RYT
Director of Holistic Healing, The Columbia Center for Integrative Medicine, Columbia, MD and Woodland Hills, CA
Yogatherapy is substantiated by both the current clinical literature and regular practice over thousands of years since the Vedic age. Customized yoga practices applied to patients with chronic inflammation/illness leads to improved sense of well-being, less pain, improved sleep, longer telomeres, less sarcopenia, improved mood, improved cardiac performance, improved joint alignment, improved cognition, and slowed aging. Here we will discuss background and technical applications of Yogatherapy for the practice of age management medicine, with specific case discussions regarding cardiac, neurologic, musculoskeletal, and gastroenterology illnesses.
8:45 – 9:30 am Functional Medicine Detoxification Protocols
Elliot Dinetz, M.D., ABFM
Timeless Health, Miami, FL
How to improve your body’s metabolism to limit disease and restore health.
9:30 – 10:15 am Reducing Toxic Load and Body Burden: Resetting the Microbiome with Botanical Medicine 
Emily Poccia, BS, N.D.
Medical Director & Owner, Wildcraft Medicine, La Jolla, CA
Clinical Consultant & Practitioner Trainer, Bio-Botanical Research
Infection and endotoxins from biofilms and pathogens in the GI tract contribute to or directly cause systemic inflammation, including autoimmune disorders, heart disease, chronic fatigue/fibromyalgia syndromes, Lyme, periodontal disease and other conditions. Biofilms and chronic infections have been difficult to address with conventional medicine, but research into plant-based approaches have demonstrated great success. The goal of this presentation is to review research and expand participants’ understanding of botanicals and the role that they play in the practice of regenerative medicine.  
10:15 – 10:30 am Break
10:30 – 11:15 am Dementia Demystified: A Functional Medicine Approach To Reversing Mild Cognitive Impairment and Dementia
Kat Toups, M.D., DFAPA, IFMCP
Private Practice, Functional Medicine Psychiatry, Bay Area Wellness, Walnut Creek, CA
Distinguished Fellow, American Psychiatric Association
Certified Practitioner, Institute for Functional Medicine
Alzheimer’s Disease is a neurodegenerative disorder – but it is not a mysterious, untreatable brain disorder. It is a reversible multisystem illness that occurs due to toxins and infections and inflammation and lack of hormones and other diet and lifestyle factors. It has a strong autoimmune component as well. Neurodegeneration does not just happen. It happens for reasons, and when we can look at the big picture and address all of the driving factors, we can gain traction in stopping and sometimes even reversing the degenerative process. Alzheimer’s Dementia is a multi-factorial disease, and it is rarely due to just one thing. In order to reverse dementia, we have to look at, and rectify, all of the factors that contribute: metabolic, nutritional, toxic, inflammatory, infectious, autoimmune, and/or withdrawal of trophic support (like hormones and nutrients). Dr. Toups will discuss the Functional Medicine approach she used to reverse her own dementia, and how to evaluate patients with Mild Cognitive Impairment and Dementia using a Functional approach to determine the root causes of their illness.
11:15 am – 12:00 pm A Case Series of Patients Presenting for Functional Medicine Treatment of Cognitive Decline
Myrto Ashe, M.D., MPH
Certified Functional Medicine Practitioner (IFM)
Private Practice, San Rafael, CA
We report on 56 patients who presented between January 15, 2017 and January 15, 2019 for reversal or stabilization of cognitive decline. A multifaceted approach described by Dr. Dale Bredesen was used as guiding methodology. We describe the population demographics, functional parameters including glucose regulation, intestinal barrier function, key nutrient and hormone levels, biotoxin impact, and chronic infections. We include dropouts from the program, describe our intervention, and report on cognitive outcome where available.
12:00 – 12:45 pm Volumetric MRI/Brain Imaging Assessments and Clinical Correlations with Dementia
Mary Beth Ackerley, M.D., MD(H), ABIHM
Private Practice, Tucson, AZ
Co-Founder and Vice President, ISEAI, the International Society of Environmentally Acquired Illness
Brain MRI imaging with computerized assessment of the volumetric measurements of multiple brain regions is routinely used for diagnosing Alzheimer’s Age-related Atrophy in the Bredesen protocol. Other uses are for Traumatic Brain Injury, changes related to environmental toxins such as mold and Lyme, and limbic dysregulation. The MRI is easily obtained at most radiology facilities and does not use radiation or require contrast. Most insurances will cover the cost with proper coding. This lecture will cover the basics in learning to interpret the reports in a way that patients can know if their aging brain is showing changes consistent with Alzheimer’s. Other cause of cognitive impairment including sequalae of traumatic brain injury, neuroinflammation and other brain regions showing neurodegeneration such as the frontal lobes and basal ganglia will be covered. Multiple treatment interventions will be discussed.
12:45 – 1:30 pm The Aging Brain: Role of Nutrition and Lifestyle in Prevention and Management of Cognitive Decline
Aarti Batavia, MS, RDN, CLT, CFSP, IFMCP
Nutrition & Wellness Consulting
Private Practice, Novi, Royal Oak and Ann Arbor, MI
Visiting Faculty, Wayne State University Coordinated Program in Dietetics. Nutrition and Food Science
“The loss of a human mind – the gradual deterioration of a lifetime’s worth of wisdom, experience and personal relationships is a tragedy.”Markham Heid.
Alzheimer’s disease is one of the most significant global health threats we face today. It is estimated that 36 million people worldwide live with dementia, with numbers expected to reach 115 million by 2050. Dementia prevention is an urgent priority, not just to reduce incidence but also to slow, stall the progression and possibly reverse cognitive decline especially in patients exhibiting early signs of the disease. A multi-modal programmatic approach utilizing functional medicine has emerged as a potential intervention to enhance clinical outcomes for individuals with dementia. In this presentation, the speaker will discuss the role of nutrition and lifestyle strategies in optimizing cognitive health.